Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in TCRT held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 21K | $48K | 0.0% | 0.874% | 0.00% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 19K | $44K | -14.2% | 0.793% | 0.00% |
| 3 | VANGUARD FIDUCIARY TRUST CO | 15K | $35K | 0.0% | 0.635% | 0.00% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 14K | $32K | 0.0% | 0.576% | 0.00% |
| 5 | CITADEL ADVISORS LLC | 12K | $27K | +12.8% | 0.486% | 0.00% |
| 6 | OSAIC HOLDINGS, INC. | 2K | $4K | -2.7% | 0.071% | 0.00% |
| 7 | Tower Research Capital LLC (TRC) | 2K | $4K | +2.4% | 0.066% | 0.00% |
| 8 | Arax Advisory Partners | 1K | $3K | β | 0.050% | 0.00% |
| 9 | UBS Group AG | 992 | $2K | -56.4% | 0.041% | 0.00% |
| 10 | MORGAN STANLEY | 836 | $2K | +28.0% | 0.034% | 0.00% |
| 11 | Vanguard Global Advisers, LLC | 501 | $1K | 0.0% | 0.021% | 0.00% |
| 12 | ROYAL BANK OF CANADA | 375 | $1K | +102.7% | 0.015% | 0.00% |
| 13 | WELLS FARGO & COMPANY/MN | 388 | $877 | +104.2% | 0.016% | 0.00% |
| 14 | Blue Trust, Inc. | 135 | $305 | 0.0% | 0.006% | 0.00% |
| 15 | Steward Partners Investment Advisory, LLC | 112 | $253 | +21.7% | 0.005% | 0.00% |
| 16 | Federation des caisses Desjardins du Quebec | 70 | $158 | 0.0% | 0.003% | 0.00% |
| 17 | BOKF, NA | 66 | $149 | β | 0.003% | 0.00% |
| 18 | Axiom Investment Management LLC | 46 | $104 | β | 0.002% | 0.00% |
| 19 | Key FInancial Inc | 24 | $54 | 0.0% | 0.001% | 0.00% |
| 20 | SIGNATUREFD, LLC | 23 | $52 | 0.0% | 0.001% | 0.00% |
| 21 | NFSG Corp | 21 | $47 | 0.0% | 0.001% | 0.00% |
| 22 | LANARK FINANCIAL, INC. | 20 | $45 | 0.0% | 0.001% | 0.00% |
| 23 | AdvisorNet Financial, Inc | 19 | $43 | 0.0% | 0.001% | 0.00% |
| 24 | BARCLAYS PLC | 15 | $34 | β | 0.001% | 0.00% |
| 25 | WEST PACES ADVISORS INC. | 10 | $23 | β | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in TCRT β a direct measure of their conviction.
Filings activity in TCRT during Q2 2026, grouped by how each filer changed its position.
Institutions that opened a new TCRT position in Q2 2026
Institutions that fully closed their TCRT position in Q2 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 29 | +0.0% | 3.70% | 1.46 pp | $0M | 37% |
| Q1 2026 | 29 | +7.4% | 5.16% | +1.47 pp | $0M | +4.1% |
| Q4 2025 | 27 | +3.8% | 3.69% | +1.30 pp | $0M | +96% |
| Q3 2025 | 26 | 10% | 2.39% | 1.00 pp | $0M | 54% |
| Q2 2025 | 29 | 3.3% | 3.39% | 0.13 pp | $0M | +232% |
| Q1 2025 | 30 | 6.3% | 3.52% | 0.07 pp | $0M | 25% |
| Q4 2024 | 32 | +10% | 3.59% | 5.98 pp | $0M | 78% |
| Q3 2024 | 29 | β | 9.57% | β | $1M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying TCRT stock.
Based on Q2 2026 13F filings, institutional ownership of Alaunos Therapeutics, Inc. stands at 3.7%, held across 29 reporting institutions.
BlackRock, Inc. is the largest reported institutional holder of TCRT, with approximately 21,353 shares worth $0.00B as of Q2 2026.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of TCRT, including CITADEL ADVISORS LLC.
Our composite Smart Money Score for TCRT is 44 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
6 institutions opened new positions in TCRT during Q2 2026, while 3 fully exited. 2 added to existing positions and 20 trimmed.
TCRT institutional ownership fell by 1.46 percentage points quarter-over-quarter, with a net change of +0 holders.
The top 10 institutions account for 97.9% of all reported 13F value in TCRT, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Alaunos Therapeutics, Inc. (TCRT) Institutional Ownership